(13223324), S. R. M., (22676321), A. R., (22676324), M. A. P., (22676327), E. Z. E., (22676330), M. D., (3480455), H. H., . . . (22676354), M. J. Y. A. (2025). Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].
Chicago Style (17th ed.) Citation(13223324), Seyed Reza Mousavi, et al. Snakebite Severity Classification in Clinical Trial of SnaFab Vs. Razi Antivenom in Snakebite Victims [14,57,58]. 2025.
MLA引文(13223324), Seyed Reza Mousavi, et al. Snakebite Severity Classification in Clinical Trial of SnaFab Vs. Razi Antivenom in Snakebite Victims [14,57,58]. 2025.
警告：這些引文格式不一定是100％准確.